Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Translational Medicine|February 16, 2021
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access programGiovanni Grignani, Vanna Chiarion Sileni, Carmine Pinto, et al.
Neuroendocrinology|August 31, 2022
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT StudyPiero Ferolla, Alfredo Berruti, Francesca Spada, et al.
Journal of Personalized Medicine|February 25, 2023
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor ResectionBarbara Altieri, Anna La Salvia, Roberta Modica, et al.
Therapeutic Advances in Medical Oncology|January 7, 2020
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational studyVincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, Dario Giuffrida, et al.
Ecancermedicalscience|June 23, 2020
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical OncologistsLivio Blasi, Roberto Bordonaro, Nicolò Borsellino, et al.
Critical Reviews in Oncology/Hematology|October 3, 2022
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paperAntongiulio Faggiano, Rossella Mazzilli, Annalisa Natalicchio, et al.
BMC Cancer|September 26, 2023
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trialFrancesca Corti, Maria Pia Brizzi, Vito Amoroso, et al.
Neuroendocrinology|August 17, 2017
Natural History of Localized and Locally Advanced Atypical Lung Carcinoids after Complete Resection: A Joined French-Italian Retrospective Multicenter StudyFrancesca Marciello, Olaf Mercier, Piero Ferolla, et al.
Frontiers in Oncology|May 4, 2023
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumabLorena Incorvaia, Alessandra Dimino, Laura Algeri, et al.
Cancer Treatment Reviews|April 11, 2024
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary groupMaria Chiara Zatelli, Antongiulio Faggiano, Antonella Argentiero, et al.
Pageof 7